| abstract |
An adenoviral vector for the treatment and prevention of cancer or AIDS is provided. A recombinant adenoviral vector encoding all or part of an antibody and containing an exogenous nucleotide sequence placed under the control of elements necessary for its expression, wherein the antibody is toxic or A recombinant adenoviral vector characterized by being modified with an immunopotentiating substance. [Selection figure] None |